Animal models of schizophrenia;Animální modely schizofrenie

Psychiatrie

Volumn 7, Issue 1, 2003, Pages 26-30

  Bubeníková, Věra ^a,b   Horáček, Jiří ^a   Benešová, Olga ^a   Šťastný, František ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^b NONE   (Czech Republic)

Author keywords

Animal models of schizophrenia; Genetic models; Glutamate; Neurodevelopmental hypotheses

Indexed keywords

DIZOCILPINE; NEUROLEPTIC AGENT; SEROTONIN ANTAGONIST;

ANIMAL MODEL; ARTICLE; DOPAMINERGIC SYSTEM; GENETIC MODEL; HYPOTHESIS; NERVE CELL DIFFERENTIATION; NEUROBIOLOGY; NONHUMAN; PATHOGENESIS; PSYCHOSIS; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM;

EID: 0037261416     PISSN: 12117579     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Ashe PC, Berry MD, Boulton AA. Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents. Prog Neuro Psychopharmacol Biol Psychiat 2001;25:691-707.
2. Bachevalier J, Alvarado MC, Malkova L. Memory and socioemotional behavior in monkeys after hippocampal damage incurred in infancy or in adulthood. Biol Psychiatry 1999;43:436-445.
3. Benešová O, Pětová J, Vinšová N. Perinatal destress and brain development. Perinatal distress and brain development. Praha: Avicenum, 1980.
4. Brake W, Boksa P, Gratton A. Influence of perinatal factors on the nucleus accumbens dopamine response to repeated stress during adulthood: an electrochemical study in adult rats. Psychopharmacology 1997;133:389-395.
5. Bowers MB, Freedman DX. "Psychedelic" experiences in acute psychoses. Arch Gen Psychiat 1966;15:240-248.
6. Bubeníková V, Horáček J, Št'asný F. Prepulzní inhibice úlekové reakce jako deficit zpracování informací. Psychiatrie 2002;6:29-32.
7. Carlsson A. Neurocircuitries and neurotransmitter interactions in schizophrenia. Int Clin Psychopharmacol 1995;10:21-28.
8. Chen Ch, Chiu YL, Shaw CK, Tsai MT, Hwang AL, Hsiao KJ. Detection of Borna disease virus RNA from peripheral blood cells in schizophrenic patients and mental health workers. Mol Psychiatry 1999;4:566-571.
9. Cotter D, Takei T, Farrell M, Sham P, Quinn P, Larkin C, Oxford J, Murray R, O'Callaghan E. Does prenatal exposure to influenza in mice induce pyramidal cell disarray in the dorsal hippocampus? Schizophr Res 1995;16:233-241.
10. Csernansky JG, Csernansky CA, Kogelman L, Montgomery EM, Bardgett ME. Progressive neurodegeneration after intracerebroventricular kainic acid administration in rats: implications for schizophrenia? Biol Psychiatry 1998;44:1143-1150.
11. Curran T, D'Arcangelo G. Role of Reelin in the control of brain development. Brain Res Brain Res Rev 1998;26:285-294.
12. El-Khodor BF, Boksa P. Birth insult increases amphetamine induced responses in the adult rat. Neuroscience 1998;87:893-904.
13. Ellenbroek BA, Geyer MA, Cools AR. The behavior of APO-SUS rats in animal models with construct validity for schizophrenia. J Neurosci 1995;11:7604-7611.
14. Ellenbroek BA, van den Kroonenberg PT, Cools AR. The effects of an early stressful life event on sensorimotor gating in adult rats. Schizophr Res 1998;30:251-260.
15. Fatami SH, Emamian ES, Kist D, Sidwell RW, Nakajima K, Akhter P, Shier A, Sheikh S, Bailey K. Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice. Mol Psychiatry 1999;4:145-154.
16. Flores G, Wood GK, Liang J-J, Quirion R, Srivastava LK. Enhanced amphetamine sensitivity and increased expression of dopamine D2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal cortex. J Neurosci 1996;16:7366-7375.
17. Gainetdinov RR, Mohn AR, Caron MG. Genetic animal models: focus on schizophrenia. TINS 2001;24:527-533.
18. Goldman PS. Functional development of the prefrontal cortex in early life and the problem of neuronal plasticity. Exp Neurol 1971;32:366-387.
19. Horning M, Weissenbock H, Horscroft N, Lipkin WI. An infectionbased model of neurodevelopmental damage. Proc Natl Acad Sci USA 1999;96:12102-12107.
20. Impagnatiello F, Guidotti AR, Pesold C, Dwivedi Y, Cauncho H, Pisu MG, Uzunov DP, Smalheiser NR, Davis JM, Pandey GN, Pappas GD, Tueting P, Sharma RP, Costa E. A decrease of Reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci USA 1998;95:15718-15723.
21. Jentsch JD, Roth RH. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1999;20:201-225.
22. Karlsson H, Bechmann S, Schröder J, McArthur J, Torrey EF, Yolken RH. Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia. Proc Nad Acad Sci USA 2001;98:4634-4639.
23. Kirkpatrick B, Conley RC, Kakoyannis A, Reep RI, Roberts RC. Interstitial cells of the white matter in the inferior parietal cortex in schizophrenia: an unbiased cell-counting study. Synapse 1999;34:95-102.
24. Kolb B, Gibb R. Anatomical correlates of behavioral changes after neonatal prefrontal lesions in rats. Prog Brain Res 1990;85:241-256.
25. Krystal JH, Karper LP, Sibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine response. Arch Gen Psychiatry 1994;199-214.
26. Lahti AC, Koffel B, LaPorte D, Tamminga CA. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 1995;13:9-19.
27. Lipska BK, Weinberger DR. Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat. Dev Brain Res 1993;75:213-222.
28. Lipska BK, Weinberger DR. Subchronic treatment with haloperidol or clozapine in rats with neonatal excitotoxic hippocampal damage. Neuropsychopharmacology 1994;10:199-205.
29. Lipska BK, Weinberger DR. To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology 2000;23:223239.
30. Logue SF, Owen EH, Rasmussen DL, Wehner JM. Assessment of locomotor activity, acoustic and tactile startle, and prepulse inhibition of startle in inbred mouse strains and F1 hybrids: implications of genetic background for single gene and quantitative trait loci analyses. Neuroscience 1997;80:1075-1086.
31. Miyamoto Y, Yamada K, Noda Y, Mori H, Mishina M, Nabeshima T. Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor epsilon 1 subunit. J Neurosci 2001; 21:750-757.
32. Mintz M, Youval G, Gigi A, Myslobodsky MS. Rats exposed to prenatal gamma-radiation at day 15 of gestation exhibit enhanced perseveration in T-maze. Soc Neurosci Abstract 1997;23:1365.
33. Moghaddam B, Adams B. Reversal of phencyclidine effects by group II metabotropic glutamate receptor agonist in rats. Science 1998; 281:1349-1352.
34. Mohn AR, Gainetdinov RR, Caron MG, Koller BH. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999;98:427-436.
35. Moore NA. Behavioural pharmacology of the new generation of antipsychotic agents. Br J Psychiatry 1999;174:5-11.
36. Morgane PJ, Austin-LaFrance R, Bronzino J, Tonkiss J, Diaz-Cintra S, Cintra L, Kemper T, Galler JR. Prenatal malnutrition and development of the brain. Neurosci Biobehav Rev 1993;17:91-128.
37. Mowry BJ, Nancarrow DJ. Molecular genetics of schizophrenia. Clin Exp Pharmacol Physiology 2001;28:66-69.
38. Nováková, V, Šterc J. Late effects of early hunger and mother litter separation on learning and memory in male rats. Physiol Behav. 1973;11:277-280.
39. O'Donnell P, Grace AA. Phencyclidine interferes with the hippocampal gating of nucleus accumbens neuronal activity in vivo. Neuroscience 1998;87:823-830.
40. O'Donovan MC, Owen MJ. Candidate-gene association studies of schizophrenia. Am J Hum Genet 1999;65:587-592.
41. Ossowska K, Pietraszek M, Wardas J, Nowak G, Zajaczkowski W, Wolfarth S, Pilc A. The role of glutamate receptors in antipsychotic drug action. Amino Acid 2000;19:87-94.
42. 2A receptor antagonist for the treatment of schizophrenia. CNS Drug Rev 1997;3:49-67.
43. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1987;1:133-152.
44. Swerdlow NR, Geyer MA. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 1998;24:285-301.
45. Talamini LM, Koch T, Ter Horst GJ, Korf J. Methylazoxymethanol acetateinduced abnormalities in the entorhinal cortex of the rat;parallels with morphological findings in schizophrenia. Brain Res 1998;789:293-306.
46. Verma A, Moghaddam B. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. J Neurosci 1996;16:373-379.
47. Weinberger DR. Schizophrenia: new phenes and new genes. Biol Psychiatry 1999;46:3-7.
48. Westergaard T, Mortensen PB, Pedersen CB, Wohlfahrt J, Melbye M. Exposure to prenatal and childhood infections and the risk of schizophrenia: suggestions from a study of sibship characteristics and influenza prevalence. Arch Gen Psychiatry 1999;56:993-998.
49. Willner P. Validation criteria for animal models of human mental disorders: learned helplessness as a paradigm case. Prog Neuropsychopharmacol Biol Psychiat 1986;10:677-690.
50. Zaharia MD, Kulczycki J, Shanks N, Meaney MJ, Anisman H. The effects of early postnatal stimulation on Morris water-maze acquisition in adult mice: genetic and maternal factors. Psychopharmacology 1996;128:227-239.